Serum cholesterol has been widely accepted as a risk factor for ischaemic heart disease. The median serum cholesterol concentration for different populations correlates closely with the prevalence of ischaemic heart disease.' Apart from the exceptional patient with monogenic familial hypercholesterolaemia,2 3 however, serum cholesterol does not discriminate well between individuals in whom ischaemic heart disease develops at an early age and those in whom it does not. In the Framingham study and in all subsequent similar population studies there was a considerable overlap between the distribution of the serumn cholesterol concentration of men in whom ischaemic heart disease developed and of those in whom it did not.4 5 It
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Accepted for publication 9 June 1986 has been calculated that more than three quarters of men in whom ischaemic heart disease develops cannot be identified by their serum cholesterol concentration and that of those whose serum cholesterol exceeds 300 mg/dl (7 7 mmolil) less than one tenth will die prematurely of ischaemic heart disease.6 Serum triglycerides do not discriminate better than total serum cholesterol,7 and serum low density lipoprotein (LDL) cholesterol and serum high density lipoprotein (HDL) cholesterol provide only marginally better discrimination. 8 This lack of ability accurately to distinguish individuals at risk poses great difficulties in planning a strategy for the prevention of ischaemic heart disease. Ideally, preventive measures should be directed at individuals most likely to benefit rather than whole nations910 or large numbers of people selected by arbitrary use of imprecise discriminants such as serum cholesterol." Serum apolipoproteins and ischaemic heart disease ease have been proposed as being potentially more discriminating. These include the HDL2 and HDL3 subfractions of serum HDL,'2 13 apolipoprotein AI (apo AI) (the major apolipoprotein of HDL),14 15 and apolipoprotein B (apo B) (the major apolipoprotein of LDL). 14 16 -18 We have compared the value of these discriminants in identifying men known to have ischaemic heart disease at an early age.
Patients and methods

PATIENTS AND CONTROLS
Male patients aged < 60 years were sought from the records of the coronary care unit of the Manchester Royal Infirmary. The hospital notes of such men were examined and surviving men with definite evidence of acute myocardial infarction'9 more than six months previously, who were not receiving treatment with ,B adrenoreceptor blocking drugs or thiazide diuretics, were invited to participate in the study, which had the approval of the hospital ethics committee. Of the men asked to take part, 79% of those still living did so. They were studied (SD) a mean of 18 8 (8 6) months after their myocardial infarction. Obese patients had generally been advised to lose weight after their myocardial infarction, but no other dietary advice had been given. The average decrease in body weight between that reported before myocardial infarction and that determined in this investigation was only 1 2 kg. The controls were volunteers from two local factories. They had no personal history of ischaemic heart disease, peripheral arterial disease, or cerebrovascular disease as assessed during an interview by one of us (PND) using the Rose questionnaire20 and supplementary questions. Both patients and controls were excluded from the study if they were known to have any chronic medical condition such as diabetes mellitus or to be on any drug or dietary treatment known to affect serum lipids. We used a standard questionnaire to obtain information about smoking habits, alcohol intake, family history of myocardial infarction before the age of 60 in the father or before the age of 70 in the mother, occupation (before heart attack in case of patients), and exercise. Patients were also asked about changes in weight, smoking, and occupation since their heart attack. Height, weight, and blood pressure after lying for 5 mined by immunoelectrophoresis29 30 with antisera supplied by Immuno Ltd (Dunton Green, Kent).
Results
CHARACTERISTICS OF PATIENTS AND CONTROLS
Patients and controls differed little in their age and body mass (table 1). They were closely matched for their socioeconomic background as judged by the Registrar General's coding (controls were 19% class I, 24% II, 28% III, 12% IV, and 17% V and patients were 17% I, 27% II, 27% III, 12% IV, and 17% V). Both groups were also similar with respect to systolic and diastolic blood pressures, the proportion who were cigarette smokers, who were teetotal, and who regularly exercised. More alcohol was drunk by the control group, but this did not achieve statistical significance. A significantly higher proportion of patients with previous myocardial infarction than of controls reported that one or both parents had suffered a premature heart attack. On average serum HDL cholesterol concentrations were higher in the controls, with the difference achieving statistical significance when the phosphotungstate method was used. Serum apo Al was also significantly lower in men with previous myocardial infarction. The difference in serum HDL cholesterol between patients and controls appeared to be largely due to variations in the concentration of cholesterol in the HDL2 subfraction. DISCRIMINANT 
ANALYSIS
Discriminating variables
Stepwise discriminant analyses were performed to determine which variables were most important in differentiating between men with previous myo- 12 13 Cigarette smokers (Go) 28 26 Considerable exercise (%) 25 
23
Parental history (%) 
Discussion
In 1974 Fredrickson, commenting about apo B, said that "its resistance to characterisation, its seeming essentiality for glyceride transport, and perhaps the Serum apolipoproteins and ischaemic heart disease 211 B concentrations in a third of the children of parents with raised serum apo B concentrations that had been discovered when the parents presented with ischaemic heart disease.34 Their observation is not necessarily incompatible with our finding that a parental history of premature myocardial infarction did not influence the concentration of serum apo B. Our subjects were not selected because of their lineage. A single gene is unlikely to determine both the risk of ischaemic heart disease and the concentration of serum apo B. It is more probable that a gene or genes participating in the development of high serum apo B concentrations may cause accelerated coronary atherogenesis when combined with other genes or familial characteristics that increase the susceptibility to atheroma. An individual with premature myocardial infarction and raised apo B concentration may have inherited this combination of factors from one parent, but, perhaps even more commonly, may do so in part from both parents. Neither parent may have a history of premature ischaemic heart disease because both influences are not operating in them.
Environmental, particularly nutritional, effects in our study may also have been more influential than in the offspring studied by Sniderman et al. 34 They were on average 17 years old and had much lower serum and LDL cholesterol concentrations than the men in our study. Genetic influences on serum apo B may be more discernible in young people, whereas in older people nutritional and other environmental effects may predominate. The diet of men in the North West of England may also be different from that in North America. Certainly the quantity and type of dietary fat can considerably alter serum apo B concentrations. 35 36 Nevertheless, genetic differences in dietary response are the simplest explanation for the difference in serum apo B concentrations between the patients and controls in our study; because they are so similar in all other respects major dietary differences are unlikely. A genetic effect on serum apo B concentrations is also suggested by their possible association with a restrictive site polymorphism in the apo B gene. 37 There has been much debate about whether serum triglycerides are a risk factor for ischaemic heart disease. 7 We have previously reported unexpectedly high levels of LDL apo B in some patients with type IV hyperlipoproteinaemia (and by definition normal LDL cholesterol).16 The present study supports the view proposed by Sniderman et al that it is this type of patient with type IV hyperlipoproteinaemia who is at risk of ischaemic heart disease.33 Our finding that the frequency of raised concentrations of serum apo B was no greater in men with hypertriglyceridaemia than in those with normal serum lipids when those with and those without ischaemic heart disease were analysed separately would also explain why serum triglycerides are such a poor risk factor. The suggestion from our earlier work that increased serum apo B might be more common in type IV hyperlipoproteinaemia"6 probably arose because some patients with type IV had been discovered because of ischaemic heart disease that was absent in the controls, and also because the hypertriglyceridaemia was more extreme than in the present investigation.
The method that we used in this study measured total serum apo B concentration. '6 29 Another method that uses radial immunodiffusion may more closely reflect serum LDL apo B concentration. 18 It is, however, unlikely that this would be a major advantage since VLDL, the other serum lipoprotein containing apo B in the fasting state, makes only a small contribution to the total apo B in serum even at VLDL concentrations exceeding any in the present study.16
The present study suggests that apo B may identify men at risk of premature heart attacks better than currently available risk factors. A finer definition of high risk patients would not only allow the more economic use of health resources, but would also allow patients to be given more definite advice and would enable drugs to be used when their benefit could more clearly be seen to outweight their possible ill effects. In developing a rational approach to the prevention of ischaemic heart disease the further evaluation of apo B as a predictive factor in prospective studies will be important if preventive measures are to be aimed at the individual rather than the whole population. 
